Kristin Post

KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas.

Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations.

Detection of cytomegalovirus infection by quantitative polymerase chain reaction.

EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder.

qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies.

Utilization of cell-transferred cytologic smears in detection of EGFR and KRAS mutation on adenocarcinoma of lung.

Performance Evaluation Comparison of 3 Commercially Available PCR-based KRAS Mutation Testing Platforms.

Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms.